Vioxx Settlement

As co-lead counsel representing people who experienced cardiovascular complications after taking arthritis medication, Vioxx, Seeger Weiss helped secure a $4.85 Billion global settlement which provided compensation to more than 45,000 plaintiffs.

Sign up for our newsletter to get updates on drugs & medical devices

If you would like to sign up for our newsletter click the button below.

Sign Up For Newsletter

$4.85 Billion Drug Injury Settlement

In 2007, Merck & Co agreed to pay $4.85 Billion to settle claims over its arthritis medication, Vioxx. The company faced an estimated 50,000 lawsuits filed by people who experienced serious side effects including heart attacks and strokes after taking Vioxx.

The settlement was offered after the first bellwether trial in Multidistrict Litigation resulted in a $253 million judgement for the plaintiff whose husband had died after using Vioxx. Lawsuits filed against the company claimed that Merck knew about the risks of cardiovascular injury but continued to sell the medication. Unusually high numbers of adverse event reports had ultimately led to the 2004 withdrawal of Vioxx from the market.

In 2016, Merck also settled a class action lawsuit for $830 million. The lawsuit was filed by investors who claimed the company had failed to accurately state the risk of heart attack associated with Vioxx, causing stockholders to lose value in their investments.